IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$438.65 USD
-16.70 (-3.67%)
Updated Sep 21, 2023 04:00 PM ET
After-Market: $438.47 -0.18 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
IDXX 438.65 -16.70(-3.67%)
Will IDXX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IDXX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IDXX
Here's Why You Should Hold on to IDEXX (IDXX) Stock Right Now
Idexx (IDXX) Down 1.6% Since Last Earnings Report: Can It Rebound?
IDXX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
Other News for IDXX
Tracking Ron Baron's BAMCO Portfolio - Q2 2023 Update
IDEXX Laboratories Inc. stock falls Thursday, underperforms market
IDEXX Laboratories Inc. stock outperforms market despite losses on the day
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day
IDEXX Laboratories Inc. stock falls Monday, underperforms market